Clinical Trial Update: The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating apatinib as maintenance monotherapy for extensive-stage small-cell lung cancer; no results or final status are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Junling Li | Conditions: Apatinib in Maintenance Treatment | Phase 2 | Status: UNKNOWN